Dr. Allan James Luistro

NPI1073648259

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$7,576.21
from 6 payments in the last 6 years

Total Cash or Cash Equivalent

$7,556.21
from 5 payments in the last 6 years

Total In-kind Items & Services

$20.00
from 1 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
02/15/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $4652.00 Details
Payment from Swedish Orphan Biovitrum AB
Payment Record ID 700033259
02/25/2019 General (Non-Research) Cash or cash equivalent Travel and Lodging $417.82 Details
Payment from Swedish Orphan Biovitrum AB
Payment Record ID 700033221
02/16/2019 General (Non-Research) In-kind items and services Food and Beverage $20.00 Details
Payment from Swedish Orphan Biovitrum AB
Payment Record ID 700033167
03/29/2016 Research Cash or cash equivalent $717.23 Details
Payment from Rhodes Pharmaceuticals L.P.
Paymment Research Study Single Dose Crossover Comparative Bioavailability Pilot Study of Mixed Salts Amphetamine 30 mg Extended-Release Capsules in Healthy Male and Female Volunteers Fed State
Payment Record ID 413499574
03/29/2016 Research Cash or cash equivalent $956.30 Details
Payment from Rhodes Pharmaceuticals L.P.
Paymment Research Study Single Dose Crossover Comparative Bioavailability Pilot Study of Mixed Salts Amphetamine 30 mg Extended-Release Capsules in Healthy Male and Female Volunteers Fasting State
Payment Record ID 413499568
03/30/2016 Research Cash or cash equivalent $812.86 Details
Payment from Rhodes Pharmaceuticals L.P.
Paymment Research Study Single Dose Crossover Adhesion and Pharmacokinetic Endpoint Pilot Study of Fentanyl 25 mcghour Transdermal Patch in Healthy Volunteers Following a 3-day Patch Application
Payment Record ID 413499556